Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90

Benzer Materyaller

• Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
  Yazar:: Sharma, Aditya P., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Author reply Re: Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
  Yazar:: Singh, Shanky, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Re: Bansal D, Nayak B, Singh P, Nayyar R, Ramachandran R, Kumar R, et al. Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy. Indian J Urol 2020;36:95-100
  Yazar:: Misra, Ankit, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Re: Guler Y, Erbin A. Comparison of extracorporeal shockwave lithotripsy and retrograde intrarenal surgery in the treatment of renal pelvic and proximal ureteral stones ≤2 cm in children. Indian J Urol 2020;36:282-7
  Yazar:: Tripathy, Sambit, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Re; Seniaray N, Verma R, Khanna S, Belho E, Pruthi A, Mahajan H. Localization and restaging of carcinoma prostate by 68Gallium prostate-specific membrane antigen positron emission tomography computed tomography in patients with biochemical recurrence. Indian J Urol 2020;36:191-9
  Yazar:: Pandey, Abhishek, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)